Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Dijon
Clinical trial register · France

Clinical Trials in Dijon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9698 matching records held by the registry are in this view. Synced 23 Oct 2026, 03:20 UTC
9698
Studies in scope
all four open statuses
6023
Recruiting now
open to new participants
1034
Lead sponsors
across recruiting studies
Top sites
Paris 2820 Lyon 1390 Bordeaux 1389 Marseille 1285 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Centre Hospitalier Universitaire Dijon102 AstraZeneca36 UNICANCER30 Centre Georges Francois Leclerc25 Hospices Civils de Lyon23
Site location
Paris2820 Lyon1390 Bordeaux1389 Marseille1285 Lille1283
All 803 locations
Target enrolment
to

Trials with a site in Dijon

815 of 9698 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer
NCT06726330Tubo-ovarian Carcinoma, High-grade Serous Carcinoma, Primary Peritoneal Carcinoma Stage III, Primary Peritoneal Carcinoma Stage IV
Centre Oscar Lambret
Not applicable
1,100
Lyon, Toulouse, Valenciennes, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble
2027-03
Not yet open
Hospices Civils de Lyon
Observational
100
Angers, Caen, Clichy, Dijon, La Tronche, Lille, Lyon, Nantes
2027-01-01
Not yet open
Remote Ischemic Postconditioning in Septic Shock
NCT07273942Adult Patients With Septic Shock Admitted in Intensive Care Unit
Hospices Civils de Lyon
Not applicable
720
Besançon, Bourg-en-Bresse, Clermont-Ferrand, Créteil, Dijon, La Tronche, Le Kremlin-Bicêtre, Lille
2027-01
Not yet open
Bristol-Myers Squibb
Phase 3
2,380
Grenoble, Angers, Nantes, Marseille, Bobigny, Brest, Dijon, Nice
2026-12-16
Not yet open
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
NCT07814001Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Refractory Large B-cell Lymphoma (LBCL), Refractory T-cell/Histiocyte-rich Large B-cell Lymphoma, Refractory Transformed Follicular Lymphoma
DrugsEpcoritamab·Lenalidomide
The Lymphoma Academic Research Organisation
Phase 2
55
Créteil, Dijon, Lille, Limoges, Lyon, Marseille, Montpellier, Nantes
2026-12
Not yet open
Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer
NCT07587827Metastatic Colorectal Cancer (CRC), Locally Advanced Colorectal Cancer, Metastatic Pancreatic Cancer, Locally Advanced Pancreatic Cancer
Centre Georges Francois Leclerc
Phase 1
77
Besançon, Dijon
2026-11-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
1,000
Amiens, Angers, Bordeaux, Brest, Bron, Clermont-Ferrand, Dijon, Épagny
2026-11-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Phase 3
150
Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Le Kremlin-Bicêtre
2026-11-01
Not yet open
Centre Hospitalier Universitaire de Besancon
Phase 2
19
Besançon, Dijon
2026-11
Not yet open
University Hospital, Angers
Phase 3
50
Angers, Besançon, Bordeaux, Bron, Dijon, La Tronche, Le Kremlin-Bicêtre, Lille
2026-11
Not yet open
Strategy for Managing Urinary Incontinence With PRP
NCT07832487Urinary Incontinence, Platelet Rich Plasma
DrugBlood test
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
41
Dijon
2026-10-30
Not yet open
University Hospital, Toulouse
Phase 4
160
Besançon, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Grenoble, Libourne
2026-10-20
Not yet open
Centre Hospitalier Universitaire Dijon
Not applicable
20
Dijon
2026-10-10
Recruiting
Effect of Immune X on Common Cold Incidence in Healthy Adults
NCT07787130Common Cold, Upper Respiratory Tract Infection (URTI)
Givaudan France Naturals
Not applicable
160
Dijon
2026-10-09
Recruiting
Chorioretinal Imaging, Vascular Biomarkers, and Ultra-Trail: A Pilot Study
NCT07748936OCT Angiography, Retinal Microcirculation, Choroidal Microcirculation, Physical Exercion
Centre Hospitalier Universitaire Dijon
Not applicable
40
Dijon
2026-10-02
Not yet open
Centre Georges Francois Leclerc
Not applicable
18
Dijon, Montpellier, Rennes, Villejuif
2026-10-01
Not yet open
Pupillometry vs. BPS (Behavioral Pain Scale) for Analgesia Management in Inpatient Intensive Care Unit Patients on Invasive Mechanical Ventilation
NCT07867678Pupillometry, Behavioral Pain Scale, Analgesia Assessment, Intensive Care Unit (ICU)
Centre Hospitalier Universitaire Dijon
Not applicable
80
Dijon
2026-10
Not yet open
University Hospital, Bordeaux
Observational
1,200
Angers, Dijon, Limoges, Lyon, Nantes, Nîmes, Paris, Pessac
2026-10
Recruiting
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
NCT07871864Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
530
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Dijon, Grenoble
2026-10
Recruiting
Corbus Pharmaceuticals Inc.
Phase 3
260
Saint-Herblain, Montpellier, Paris, Bordeaux, Dijon, Lyon, Marseille
2026-09-29
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
150
Dijon
2026-09-23
Recruiting
Volta Medical
Not applicable
125
Avignon, Bron, Dijon, Marseille, Strasbourg
2026-09-22
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
100
Dijon
2026-09-18
Recruiting
Daiichi Sankyo
Phase 1/2
220
Caen, Dijon, Lille, Lyon, Marseille, Montpellier, Nice, Nîmes
2026-09-17
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
255
Dijon
2026-09-16
Recruiting
Vividion Therapeutics, Inc.
Phase 2
140
Besançon, Dijon, Brest, Marseille
2026-09-11
Recruiting
Bristol-Myers Squibb
Phase 3
850
Marseille, Dijon, Nantes, La Tronche, Lyon, Paris, Bron, Villejuif
2026-09-08
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
200
Dijon
2026-09-07
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
20
Dijon
2026-09-05
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
30
Dijon
2026-09-03
Not yet open
Fondation Hôpital Saint-Joseph
Not applicable
2,400
Angers, Bobigny, Bordeaux, Clermont-Ferrand, Dijon, Le Plessis-Robinson, Lille, Lyon
2026-09-01
Not yet open
Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device
NCT07273929Primary Implantation of an Intracardiac Electronic Device Indication
Hospices Civils de Lyon
Phase 3
900
Clermont-Ferrand, Dijon, Lyon, Massy, Metz, Saint-Priest-en-Jarez
2026-09-01
Not yet open
University Hospital, Rouen
Not applicable
206
Dijon, Lille, Nancy, Nantes, Paris, Rouen, Toulouse
2026-09-01
Not yet open
Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy
NCT07547033Pancreatic Adenocarcinoma, Pancreatic Head Cancer
Assistance Publique - Hôpitaux de Paris
Not applicable
150
Amiens, Angers, Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Limoges
2026-09-01
Not yet open
University Hospital, Strasbourg, France
Not applicable
136
Colmar, Dijon, Haguenau, Metz, Mulhouse, Nancy, Reims, Strasbourg
2026-09-01
Not yet open
Hospices Civils de Lyon
Phase 3
360
Amiens, Chalon-sur-Saône, Dieppe, Dijon, Garches, La Roche-sur-Yon, Le Mans, Lyon
2026-09-01
Not yet open
Centre Hospitalier Universitaire Dijon
Observational
51
Dijon
2026-09
Not yet open
University Hospital, Bordeaux
Phase 2
120
Bordeaux, Dijon, Lyon, Marseille, Montreuil, Nantes, Paris, Toulouse
2026-09
Not yet open
Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic Neurodevelomental Disorders
NCT07755098Intellectual Disability, Neurodevelopmental Disorder (Diagnosis), srGS, lrGS
Centre Hospitalier Universitaire Dijon
Not applicable
132
Dijon
2026-09
Not yet open
A Study of Taste- and Olfactory-Evoked Potentials in Patients With Visual Impairment: Taste, Smell, and Vision
NCT07707219Central Visual Impairment, Peripherical Visual Impairment, Macular Retinal Dystrophy, Peripherical Macular Dystrophy
Centre Hospitalier Universitaire Dijon
Not applicable
50
Dijon
2026-09
Not yet open
SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer
NCT07241273Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Cancers, Oropharyngeal Carcinoma, Head and Neck
UNICANCER
Not applicable
128
Brest, Caen, Dijon, Le Havre, Lille, Montpellier, Paris, Rouen
2026-09
Recruiting
Fermented Dairy Product and Bifidobacterium Diversity
NCT07700381A03 - Digestive System, B03 - Bacteria
Danone Global Research & Innovation Center
Not applicable
115
Dijon
2026-08-26
Recruiting
AstraZeneca
Phase 3
2,500
Bobigny, Colmar, Dijon, Paris, Pessac, Pierre-Bénite, Thionville, Toulouse
2026-08-19
Recruiting
VarmX B.V.
Phase 3
800
Saint Priest En Jarez, Angers, Dijon, Pierre-Bénite, Strasbourg
2026-08-18
Recruiting
Nantes University Hospital
Not applicable
788
Angoulême, Brive-la-Gaillarde, Caen, Cannes, Cherbourg, Clermont-Ferrand, Dijon, La Roche-sur-Yon
2026-08-13
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
100
Dijon
2026-08-03
Not yet open
Institut Curie
Not applicable
150
Dijon, Paris, Saint-Cloud
2026-08-01
Not yet open
ARCAGY/ GINECO GROUP
Phase 1/2
43
Bordeaux, Caen, Dijon, Lyon, Marseille, Montpellier, Pierre-Bénite, Rennes
2026-08
Recruiting
Guerbet
Phase 3
315
Bordeaux, Bron, Dijon, Poitiers
2026-07-28
Recruiting
Bristol-Myers Squibb
Phase 2
260
Dijon, Pierre-Bénite, Villejuif, Paris
2026-07-27
Recruiting
Nantes University Hospital
Phase 2
136
Angers, Bordeaux, Brest, Dijon, Nantes, Paris, Rennes, Strasbourg
2026-07-16
Recruiting
Boehringer Ingelheim
Phase 3
390
Clichy, Dijon, Lyon, Marseille, Pessac, Rennes, Toulouse, Villejuif
2026-07-10
Recruiting
Ipsen
Observational
30
Bron, Dijon, Le Kremlin-Bicêtre, Marseille, Montpellier, Paris, Toulouse, Villejuif
2026-07-10
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
2,000
Dijon, Étampes, Garches, Haguenau, La Roche-sur-Yon, Le Mans, Nancy, Nantes
2026-07-09
Recruiting
Centre Georges Francois Leclerc
Phase 1/2
24
Dijon
2026-07-07
Not yet open
Centre Paul Strauss
Phase 2
42
Dijon, Strasbourg
2026-07-01
Not yet open
Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation
NCT07648329Atrial Fibrillation (AF), Cardiac Arrhythmia, Atrial Fibrillation Ablation, BDNF
DrugBlood draw
Centre Hospitalier Universitaire Dijon
Observational
150
Dijon
2026-07
Not yet open
Centre Hospitalier Universitaire Dijon
Not applicable
250
Dijon
2026-07
Not yet open
UNICANCER
Phase 2/3
160
Angers, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille
2026-07
Not yet open
The Lymphoma Academic Research Organisation
Observational
129
Amiens, Angers, Avignon, Besançon, Clermont-Ferrand, Créteil, Dijon, La Roche-sur-Yon
2026-06-30
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
50
Dijon
2026-06-28
Recruiting
Efficacy of 12-week Daytime Restricted Eating on Hepatic Steatosis of Obesity
NCT07378072MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
Nantes University Hospital
Not applicable
72
Angers, Bordeaux, Dijon, Lyon, Marseille, Montpellier, Nantes, Paris
2026-06-17
Not yet open
Liquid Biopsy in Early Colorectal Lesions
NCT07319104Colorectal Neoplasms, Precancerous Conditions, Adenocarcinoma of the Colon
University Hospital, Montpellier
Observational
1,000
Amiens, Bordeaux, Brest, Dijon, Limoges, Lyon, Montpellier, Nancy
2026-06-15
Recruiting
Nantes University Hospital
Phase 3
422
Aix-les-Bains, Angers, Besançon, Bordeaux, Brest, Créteil, Dijon, Grenoble
2026-06-11
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
NCT07359820FGFR2 Gene Fusion/Rearrangement, Other Solid Tumors, Adult
Elevar Therapeutics
Phase 2
30
Bordeaux, Dijon, Lyon, Paris
2026-06-04
Not yet open
Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis
NCT07665788Ventilator-Associated Pneumonia, Ventilator-Associated Tracheobronchitis
University Hospital, Tours
Phase 3
250
Angers, Argenteuil, Blois, Bourg-en-Bresse, Créteil, Dieppe, Dijon, Dreux
2026-06-01
Not yet open
University Hospital, Toulouse
Not applicable
216
Angers, Clichy, Dijon, Lyon, Nantes, Paris, Pessac, Toulouse
2026-06-01
Not yet open
Gustave Roussy, Cancer Campus, Grand Paris
Observational
1,100
Caen, Clermont-Ferrand, Clichy, Dijon, Lille, Lyon, Marseille, Paris
2026-06
Recruiting
Assistance Publique Hopitaux De Marseille
Observational
75
Saint-Denis, Annecy, Bordeaux, Caen, Chambéry, Clermont-Ferrand, Dijon, Grenoble
2026-05-28
Recruiting
Combined Distal Femoral Nerve Block for Pain Control After Knee Replacement
NCT07629388Pain After Total Knee Arthroplasty, Pain Management
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
240
Dijon
2026-05-26
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
60
Dijon
2026-05-12
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 3
1,660
Dijon
2026-05-07
Not yet open
Olfactory Communication in the First Days of Life: From Chemical Mechanisms to Improved Breastfeeding
NCT07616076Mother Who Has Given Birth to a Singleton Newborn, Mother-newborn Dyad, Singleton Newborn
Centre Hospitalier Universitaire Dijon
Observational
364
Dijon
2026-05
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Besançon, Brest, Dijon, Lyon, Paris, Pierre-Bénite, Saint-Herblain, Strasbourg
2026-04-17
Recruiting
Boehringer Ingelheim
Phase 3
670
Angers, Bordeaux, Caen, Dijon, Nantes, Paris, Toulouse, Villefranche-sur-Saône
2026-04-13
Recruiting
Incyte Corporation
Phase 3
588
Brest, Dijon, Lille, Lyon, Marseille, Montpellier, Paris, Pessac
2026-04-09
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 3
390
Dijon
2026-04-07
Not yet open
University Hospital, Tours
Phase 4
200
Amiens, Bordeaux, Chambray-lès-Tours, Créteil, Dijon, La Tronche, Le Mans, Lille
2026-04-01
Not yet open
Centre Georges Francois Leclerc
Not applicable
70
Dijon
2026-04-01
Not yet open
Tocilizumab in Chronic Inflammatory CPPD Disease
NCT07254637Calcium Pyrophosphate Deposition Disease
DrugTocilizumab
Assistance Publique - Hôpitaux de Paris
Phase 2
80
Lomme, Paris, Corbeil-Essonnes, Dijon, Nantes, Rennes, Saint-Etienne
2026-04
Not yet open
Hospices Civils de Lyon
Phase 2
122
Amiens, Bobigny, Caen, Clichy, Créteil, Dijon, Grenoble, Lille
2026-04
Not yet open
Centre Hospitalier Universitaire Dijon
Not applicable
312
Dijon
2026-04
Recruiting
Otto Bock France SNC
Not applicable
77
Berck, Créteil, Dijon, Gaillac-Toulza, Garches, Lomme, Lyon, Nice
2026-03-30
Recruiting
Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock
NCT07179276Sepsis - to Reduce Mortality in the Intensive Care Unit, Septic Shock
University Hospital, Clermont-Ferrand
Not applicable
750
Angers, Aurillac, Bayonne, Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Le Puy-en-Velay
2026-03-29
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
60
Villejuif, Bordeaux, Dijon, Marseille, Paris, Saint-Herblain, Vandœuvre-lès-Nancy
2026-03-25
Recruiting
University Hospital, Tours
Observational
149
Angers, Bordeaux, Brest, Dijon, Grenoble, Lille, Lyon, Marseille
2026-03-23
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
60
Dijon
2026-03-18
Recruiting
Bristol-Myers Squibb
Phase 3
850
Bordeaux, Lyon Cedex08, Dijon, Montpellier, Saint-Herblain, Toulouse, Lille, Villejuif
2026-03-16
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Angers, Bois-Guillaume, Dijon, Paris, Pessac, Pierre-Bénite, Poitiers, Saint-Herblain
2026-03-16
Recruiting
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
NCT07317102Diabetes, Type 1 Diabetes, Diabetes Mellitus
Insulet Corporation
Observational
152
Angers, Besançon, Bobigny, Bordeaux, Brest, Bron, Corbeil-Essonnes, Dijon
2026-03-16
Recruiting
Novartis Pharmaceuticals
Phase 2
272
Lyon, Créteil, Dijon, Paris
2026-03-09
Recruiting
Tandem Diabetes Care, Inc.
Observational
350
Agen, Angers, Bron, Dijon, Lyon, Mainvilliers, Marseille, Meaux
2026-03-03
Recruiting
Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer
NCT06755359Pancreatic Cancer, Locally Advanced Pancreatic Cancer
Alpha Tau Medical LTD.
Not applicable
40
Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lyon, Marseille, Poitiers, Villejuif
2026-03-01
Not yet open
Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus
NCT07383779Convulsive Refractory Status Epilepticus, Status Epilepticus
Versailles Hospital
Phase 3
466
Boulogne-Billancourt, Brest, Cannes, Colombes, Corbeil-Essonnes, Dijon, Le Chesnay, Le Mans
2026-03-01
Not yet open
Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
NCT07376512Non-Small Cell Lung Cancer, Melanoma (Skin Cancer)
Centre Georges Francois Leclerc
Observational
378
Besançon, Dijon, Lyon
2026-03-01
Not yet open
Groupe français d'étude des Maladies Inflammatoires de loeil
Observational
80
Aix-en-Provence, Caen, Dijon, Le Mans, Marseille, Melun, Montfermeil, Nantes
2026-03-01
Recruiting
Halo Sign Vanishing Time After Steroids Outbreak in GCA Patients
NCT07060274Giant Cell Arteritis (GCA), Doppler Ultrasound
Centre Hospitalier le Mans
Not applicable
64
Le Mans, Angers, Caen, Dijon, La Rochelle, Nantes
2026-02-27
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 3
129
Angers, Avignon, Besançon, Boulogne, Caen, Chambray-lès-Tours, Dijon, Grenoble
2026-02-06
Recruiting
Nantes University Hospital
Observational
1,000
Bordeaux, Brest, Clermont-Ferrand, Dijon, La Rochelle, Limoges, Montpellier, Nantes
2026-02-03
Recruiting
Home Treatment of Patients With Active Cancer and Acute Pulmonary Embolism Without HESTIA Criteria.
NCT07315347Active Cancer and Symptomatic or Incidental Pulmonary Embolism Without HESTIA Criteria
Assistance Publique - Hôpitaux de Paris
Not applicable
824
Colombes, Dijon, Paris, Pierre-Bénite, Villejuif, Amiens, Angers, Brest
2026-02-02
Recruiting
Hip Abduction and Adduction During Neurodynamic Stretching
NCT07350434Stretching, Control Condition
University of Burgundy
Not applicable
12
Dijon
2026-02-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
30
Blois, Bondy, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Le Kremlin-Bicêtre
2026-01-30
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
DrugsSigvotatug vedotin·PF-08634404
Pfizer
Phase 1/2
162
Bordeaux, Dijon, Marseille, Paris
2026-01-30
Recruiting
URGO MICKAEL Filmogel, Topical Treatment of Onychomycosis
NCT07828184Onychomycosis of Toenail
CEN Biotech
Not applicable
54
Dijon
2026-01-28
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
60
Dijon
2026-01-26
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
72
Dijon
2026-01-22
Not yet open
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
120
Dijon, Montpellier, Rennes, Saint-Herblain, Lille, Villeurbanne, Rouen, Avignon
2026-01-15
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
50
Dijon
2026-01-12
Recruiting
Pharmaceutical Management in Targeted Radioligand Therapy
NCT07389512Cancer, Thyroid Cancer, Metastatic Prostate Cancer, Neuroendocrine Tumor Carcinoid
Hospices Civils de Lyon
Observational
600
Bron, Dijon, Lille
2026-01-09
Recruiting
Rennes University Hospital
Phase 3
532
Angers, Bordeaux, Brest, Caen, Dijon, Grenoble, Lille, Marseille
2026-01-07
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Nice, Pessac, Caen, Dijon, Besançon, Brest, Toulouse, Montpellier
2026-01-02
Not yet open
Centre Hospitalier Universitaire de Besancon
Phase 2
98
Besançon, Dijon, Marseille, Paris
2026-01
Not yet open
University Hospital, Toulouse
Phase 2
50
Bordeaux, Dijon, Montpellier, Nantes, Toulouse
2026-01
Recruiting
Descriptive Study of Psychiatric Symptoms in White-Sutton Syndrome
NCT07380594People With White Sutton Syndrome
Centre Hospitalier Universitaire Dijon
Observational
30
Dijon
2026-01
Recruiting
Incyte Corporation
Phase 2
56
Angers, Caen, Créteil, Dijon, Pessac, Toulouse, Vandœuvre-lès-Nancy
2025-12-29
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
75
Besançon, Dijon, Grenoble, Lyon, Montpellier, Paris, Rennes, Tours
2025-12-22
Recruiting
Eli Lilly and Company
Phase 3
800
Avignon, Besançon, Brest, Clermont-Ferrand, Dijon, Le Mans, Lyon, Montpellier
2025-12-22
Recruiting
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
NCT07322913Carotid Artery Diseases, Aortic Diseases, Peripheral Arterial Diseases
Intervascular
Observational
1,200
Dijon
2025-12-19
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 4
1,052
Saint-Etienne, Annecy, Besançon, Bordeaux, Brest, Chambéry, Créteil, Dijon
2025-12-17
Recruiting
Merck Sharp & Dohme LLC
Phase 2
180
Dijon, Angers, Clermont-Ferrand
2025-12-12
Recruiting
Pfizer
Phase 3
800
Villejuif, Brest, Dijon, Lille, Paris, Poitiers, Créteil
2025-12-11
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 3
133
Besançon, Bordeaux, Brest, Caen, Créteil, Dijon, Grenoble, La Roche-sur-Yon
2025-12-09
Recruiting
Glofitamab in Real Life
NCT06994169Large B-cell Lymphoma
DrugGlofitamab
The Lymphoma Academic Research Organisation
Observational
250
Argenteuil, Avignon, Bayonne, Besançon, Clamart, Créteil, Dijon, Dunkirk
2025-12-01
Recruiting
Innovative Biomarkers of Cardiovascular Complications Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Treatments: a Single-center Cohort Study
NCT07174141Treatment With Second-generation Bruton's Tyrosine Kinase Inhibitors (Acalabrutinib, Zanubrutinib)
DrugBlood sample
Centre Hospitalier Universitaire Dijon
Observational
100
Dijon
2025-11-28
Recruiting
Genmab
Phase 3
660
Clermont-Ferrand, Grenoble, Strasbourg, Dijon, Brest, Bordeaux, Orléans, Reims
2025-11-28
Recruiting
Creation of a Digital Twin for Predicting the Progression of Patients With Chronic Thoracic Aortic Dissection
NCT07315178Type A Aortic Dissection With Residual Type B Dissection, Chronic Type B Aortic Dissection
DrugBlood sampling
Centre Hospitalier Universitaire Dijon
Not applicable
400
Dijon
2025-11-25
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Bordeaux, Dijon, Limoges, Marseille, Nantes, Nice, Paris
2025-11-24
Recruiting
GCS Ramsay Santé pour l'Enseignement et la Recherche
Not applicable
100
Dijon
2025-11-20
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
162
Dijon, Grenoble, Paris, Suresnes, Toulon, Villejuif
2025-11-17
Recruiting
UNICANCER
Phase 2/3
196
Bordeaux, Clichy, Dijon, Marseille, Montpellier, Nantes, Paris, Poitiers
2025-11-14
Recruiting
AbbVie
Phase 2
400
Strasbourg, Dijon, Caen, Plérin, Bordeaux, Saint-Cloud, Reims, Limoges
2025-11-13
Active, closed
Novartis Pharmaceuticals
Phase 2
34
Antony, Dijon, Martigues, Nice
2025-11-10
Recruiting
Intergroupe Francophone de Cancerologie Thoracique
Phase 2
152
Angers, Avignon, Boulogne, Brest, Caen, Créteil, Dijon, Le Mans
2025-11-07
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
65
Nice, Nantes, Pierre-Bénite, Dijon, Lille, Marseille, Montpellier, Paris
2025-11-06
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
49
Caen, Dijon, Grenoble, Limoges, Marseille, Nancy, Nantes, Poitiers
2025-10-30
Recruiting
University Hospital, Brest
Not applicable
2,400
Brest, Amiens, Angers, Clamart, Clermont-Ferrand, Colombes, Dijon, Le Mans
2025-10-30
Recruiting
Clinical Performance of XPEO-E Liner in SERF Dual-mobility Cups
NCT06917365Total Hip Arthroplasty (THA)
Societe dEtude, de Recherche et de Fabrication
Observational
500
Dijon, Lyon, Saint-Etienne, Strasbourg
2025-10-27
Recruiting
Daiichi Sankyo
Phase 3
686
Angers, Bordeaux, Boulogne-Billancourt, Bron, Créteil, Dijon, Lille, Lyon
2025-10-24
Recruiting
Sanofi
Phase 3
60
Créteil, Dijon, Pessac, Toulouse
2025-10-24
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
Lyon, Clermont-Ferrand, Dijon, Besançon, Toulouse, Saint-Cloud, Montpellier, Vandœuvre-lès-Nancy
2025-10-23
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
70
Angers, Bordeaux, Dijon, Lyon, Montpellier, Paris, Rouen, Strasbourg
2025-10-21
Recruiting
Eli Lilly and Company
Phase 3
4,500
Amiens, Angers, Besançon, Clichy, Dijon, La Roche-sur-Yon, Lille, Limoges
2025-10-15
Recruiting
Institut Claudius Regaud
Phase 4
210
Angers, Dijon, Lille, Marseille, Nîmes, Paris, Rennes, Strasbourg
2025-10-15
Recruiting
Gait and Energy Expenditure in Children With Lower Limb Amputation (MAPEDE)
NCT07076602Amputation of Lower Extremity, All Causes
Rennes University Hospital
Observational
48
Berck, Brest, Bron, Dijon, Lyon, Rennes, Saint-Maurice, Valenton
2025-10-13
Recruiting
Novartis Pharmaceuticals
Phase 2
140
Angers, Bron, Dijon, Montpellier, Paris, Toulouse, Tours
2025-10-09
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Amiens, Bron, Chambray-lès-Tours, Créteil, Dijon, La Roche-sur-Yon, La Tronche, Marseille
2025-10-02
Recruiting
Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma
NCT07028125Renal Cell Carcinoma (Kidney Cancer), Metastatic Renal Cell Carcinoma, Locally Advanced
Centre Francois Baclesse
Phase 4
83
Annecy, Avignon, Bayeux, Boulogne-sur-Mer, Caen, Coudekerque-Branche, Creil, Dijon
2025-10-01
Recruiting
Natural History of Type 1 Interferonopathies: Insights From a European Cohort
NCT07040774Genetic Disease, Immune Dysfunction, Neurological Diseases or Conditions, Autoimmune Diseases
Imagine Institute
Observational
500
Angers, Ars-Laquenexy, Besançon, Bordeaux, Brest, Bron, Dijon, Gleizé
2025-10-01
Not yet open
Assistance Publique - Hôpitaux de Paris
Observational
150
Amiens, Besançon, Bordeaux, Brest, Bron, Caen, Dijon, Grenoble
2025-10
Recruiting
Alfasigma S.p.A.
Phase 3
80
Bron, Dijon, Lille, Montpellier, Rennes, Tours
2025-09-29
Recruiting
Sanofi
Phase 3
124
Clichy, Dijon, Lille, Lyon, Marseille, Pessac, Suresnes
2025-09-26
Recruiting
SOcioeconomics Status and Post-Intensive Care Syndrome
NCT06697236Post Intensive Care Syndrome (PICS)
Centre Hospitalier Universitaire Dijon
Observational
180
Dijon
2025-09-26
Recruiting
Study of the Determinants of Coronary Atherosclerosis in Familial Hypercholesterolemia (ATHERO-FH Study)
NCT06960902Familial Hypercholesterolemias, Atherosclerotic Cardiovascular Disease (ASCVD)
Nantes University Hospital
Not applicable
600
Dijon, Lille, Lyon, Marseille, Nantes, Paris, Rennes, Strasbourg
2025-09-25
Recruiting
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
Observational
120
Dijon
2025-09-24
Active, closed
Bristol-Myers Squibb
Phase 2
76
Dijon, Suresnes, Paris
2025-09-19
Not yet open
DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
NCT06884384Antiphospholipid Syndrome (APS), Cohort Study, Thrombotic and Bleeding Events
Central Hospital, Nancy, France
Observational
310
Vandœuvre-lès-Nancy, Amiens, Besançon, Brest, Dijon, Lyon, Metz, Mulhouse
2025-09-15
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 1/2
12
Dijon
2025-09-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Bordeaux, Lyon, Dijon, Toulouse, Montpellier, Rennes, Saint-Herblain, Reims
2025-09-11
Recruiting
Pfizer
Phase 3
140
Bron, Dijon, Lille, Nice, Toulouse
2025-09-10
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
200
Dijon
2025-09-09
Recruiting
AbbVie
Observational
700
Dijon, Niort, Romans-sur-Isère, Beauvais, Le Mans, Toulon, Boulogne-Billancourt
2025-09-09
Recruiting
Hôpital NOVO
Not applicable
190
Aix-en-Provence, Brest, Caen, Dijon, Nantes, Paris, Pontoise, Tours
2025-09-04
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Bordeaux, Brest, Dijon, Lille, Lyon, Paris, Pierre-Bénite, Saint-Herblain
2025-09-02
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Dijon, Epagny Metz-Tessy, La Tronche, Lille, Lyon, Nantes, Nice, Paris
2025-09-02
Recruiting
AbbVie
Observational
2,795
Dijon, Besançon, Bordeaux, Toulouse, Rennes, Chambray-lès-Tours, La Tronche, Lorient
2025-09-02
Active, closed
Nexira
Not applicable
38
Dijon
2025-09-01
Not yet open
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
160
Bayonne, Bordeaux, Brest, Carcassonne, Clermont-Ferrand, Dijon, Lille, Marseille
2025-09
Recruiting
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
NCT07169734Cervical Squamous Cell Carcinoma, Squamous Non-small-cell Lung Cancer, Colorectal Cancer, Intrahepatic Cholangiocarcinoma
Alentis Therapeutics AG
Phase 1/2
180
Dijon, Marseille, Toulouse, Villejuif
2025-08-26
Recruiting
The Lymphoma Academic Research Organisation
Phase 1/2
49
Caen, Clermont-Ferrand, Créteil, Dijon, La Tronche, Le Mans, Lille, Marseille
2025-08-20
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
20
Dijon
2025-08-18
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
55
Dijon
2025-08-02
By invitation
the REMONO-CD and the REMONO-UC Studies
NCT07564609Crohn Disease (CD), Ulcerative Colitis (UC)
University Hospital, Clermont-Ferrand
Observational
420
Amiens, Besançon, Clermont-Ferrand, Clichy, Créteil, Dijon, Grenoble, Le Kremlin-Bicêtre
2025-08-01
Active, closed
Pfizer
Phase 3
208
Bron, Dijon, Lille, Nice, Toulouse
2025-07-31
Recruiting
Eli Lilly and Company
Phase 1/2
68
Créteil, Dijon
2025-07-30
Recruiting
Hospices Civils de Lyon
Not applicable
482
Bordeaux, Dijon, Grenoble, Jossigny, Lille, Lyon, Marseille, Nantes
2025-07-25
Recruiting
Amgen
Phase 3
12,800
Besançon, Dijon, Grenoble, Le Coudray, Le Creusot, Lyon, Marseille, Nice
2025-07-25
Recruiting
Windward Bio
Phase 2
600
Pessac, Dijon, Montpellier, La Tronche, Nantes
2025-07-24
Recruiting
Celcuity Inc
Phase 3
1,180
Amiens, Caen, Dijon, Le Mans, Marseille, Pierre-Bénite, Poitiers, Villejuif
2025-07-24
Recruiting
CongenItal Naevus Cohort for Longitudinal Evaluation
NCT06828822Naevi, Neurodevelopmental Disorder, Congenital Nevus
Nantes University Hospital
Not applicable
819
Nice, Marseille, Dijon, La Réunion, Brest, Bordeaux, Toulouse, Rennes
2025-07-23
Active, closed
French Prospective Multicentric Study in Real World
NCT07039942Diabetes, Diabetes Mellitus, Type 1 Diabetes
Insulet Corporation
Observational
304
Angers, Besançon, Bobigny, Bordeaux, Brest, Bron, Corbeil-Essonnes, Dijon
2025-07-23
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
50
Dijon
2025-07-16
Recruiting
Pfizer
Phase 3
300
Lille, Dijon, Paris
2025-07-14
Recruiting
Bristol-Myers Squibb
Phase 3
586
Nice, Toulouse, Rouen, Montpellier, Reims, Villeurbanne, Dijon
2025-07-14
Recruiting
4TEEN4 Pharmaceuticals GmbH
Phase 1/2
90
Bobigny, Dijon, Lille, Limoges, Nancy, Paris
2025-07-13
Recruiting
University Hospital, Limoges
Phase 3
326
Angers, Argenteuil, Belfort, Brive-la-Gaillarde, Chalon-sur-Saône, Dijon, Garches, Le Chesnay
2025-07-09
Recruiting
Centre Hospitalier Régional d'Orléans
Not applicable
150
Orléans, Belfort, Clermont-Ferrand, Dax, Dijon, Le Coudray, Le Mans, Mont-de-Marsan
2025-07-04
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 3
294
Dijon
2025-07-02
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Chambray-lès-Tours, Créteil, Dijon, La Tronche, Marseille, Martinique, Montpellier, Paris
2025-07-02
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms
DrugsEpirubicin·Adriamycin·Xeloda·Sacituzumab tirumotecan
Merck Sharp & Dohme LLC
Phase 3
2,400
Marseille, Dijon, Saint-Cloud, Montpellier, Rennes, Pierre-Bénite, Amiens, Créteil
2025-06-30
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Amiens, Béziers, Bron, Dijon, Lille, Montpellier, Nantes, Nice
2025-06-25
Recruiting
Study of Emotional Regulation and Underlying Prefrontal Activity in Binge Eating Disorder
NCT06864065Binge-Eating Disorder, Emotional Eating, Healthy Volunteers
Centre Hospitalier Universitaire de Besancon
Not applicable
80
Besançon, Dijon
2025-06-24
Recruiting
Ventricular Arrhythmias in Acute Myocardial Infarction
NCT07517523Ventricular Arrhythmia, Acute Myocardial Infarction (AMI)
Poitiers University Hospital
Observational
500
Caen, Dijon, Grenoble, Paris, Pau, Poitiers, Saint-Etienne, Tours
2025-06-20
Recruiting
Groupe Francais De Pneumo-Cancerologie
Phase 2
45
Brest, Caen, Chambéry, Colmar, Créteil, Dijon, Épagny, La Chaussée-Saint-Victor
2025-06-19
Recruiting
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
NCT06934538Unresectable Metastatic Colorectal Cancer, Unresectable Locally Advanced Colorectal Cancer
Brenus Pharma
Phase 1/2
90
Bordeaux, Dijon, Lyon, Montpellier, Poitiers, Villejuif
2025-06-17
Recruiting
Femoral Versus Radial Invasive Arterial Pressure Monitoring in Cardiac Surgery Patients
NCT06952907Vasoplegia Syndrome, Vasoplegia, Cardiac Surgical Procedures, Arterial Pressure
Guillaume BESCH
Not applicable
340
Besançon, Dijon
2025-06-15
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
166
Caen, Dijon, Lille, Lyon, Marseille, Clichy, Paris, Villejuif
2025-06-12
Recruiting
GlaxoSmithKline
Phase 1/2
346
Dijon, Marseille, Paris, Poitiers, Rennes, Villejuif
2025-06-11
Active, closed
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136Heterozygous Familial Hypercholesterolaemia
DrugAZD0780
AstraZeneca
Phase 3
473
Bron, Dijon, Marseille, Paris, Saint-Herblain
2025-06-10
Recruiting
AstraZeneca
Phase 3
15,100
Bordeaux, Brest, Bron, Corbeil-Essonnes, Dijon, La Tronche, Lille, Limoges
2025-06-04
Not yet open
Centre Georges Francois Leclerc
Phase 2
54
Dijon
2025-06-01
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bordeaux, Brest, Caen, Carassonne, Dijon, Lille, Lyon, Montpellier
2025-05-22
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 4
50
Angers, Dijon, Lyon, Paris, Toulouse, Tours, Villejuif
2025-05-16
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Angers, Bordeaux, Chambray-lès-Tours, Dijon, Lille, Lyon, Marseille, Montpellier
2025-05-15
Recruiting
Central Hospital, Nancy, France
Phase 3
256
Besançon, Dijon, Nancy, Reims, Schiltigheim, Strasbourg
2025-05-14
Recruiting
ANRS, Emerging Infectious Diseases
Phase 1/2
238
Dijon, Lyon, Paris, Saint-Priest-en-Jarez, Tours
2025-05-09
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
5,000
Angers, Besançon, Dijon, Nantes, Rennes
2025-05-05
Not yet open
Nantes University Hospital
Phase 2
176
Angers, Bayonne, Besançon, Caen, Clamart, Clermont-Ferrand, Créteil, Dijon
2025-05-01
Recruiting
Institut Cancerologie de l'Ouest
Phase 3
84
Brest, Caen, Chambray-lès-Tours, Dijon, Le Havre, Lyon, Rennes, Saint-Herblain
2025-04-29
Recruiting
Mirati Therapeutics Inc.
Phase 3
630
Mulhouse, Caen, Dijon, Brest, Montpellier, La Tronche, Angers, Vandœuvre-lès-Nancy
2025-04-24
Recruiting
Institut du Cancer de Montpellier - Val d'Aurelle
Not applicable
254
Dijon, Nîmes, Bordeaux, Montpellier, Angers, Lyon
2025-04-15
Recruiting
University Hospital, Limoges
Phase 4
162
Besançon, Clichy, Dijon, Grenoble, Lille, Limoges, Lyon, Marseille
2025-04-15
Recruiting
Nantes University Hospital
Phase 3
1,218
Angers, Brest, Chartres, Dijon, Grenoble, La Roche-sur-Yon, Le Kremlin-Bicêtre, Le Mans
2025-04-14
Recruiting
Medical University of Vienna
Observational
200
Dijon
2025-04-11
Recruiting
UNICANCER
Phase 3
700
Brest, Dijon, Paris, Saint-Etienne, Villejuif
2025-04-10
Recruiting
AstraZeneca
Phase 3
830
Angers, Avignon, Boulogne-Billancourt, Caen, Chambéry, Dijon, La Tronche, Limoges
2025-04-10
Recruiting
Daiichi Sankyo
Phase 3
510
Avignon, Brest, Dijon, Montpellier, Paris, Poitiers, Rennes, Strasbourg
2025-03-27
Recruiting
UNICANCER
Phase 2
73
Amiens, Angers, Avignon, Besançon, Cholet, Dijon, Lyon, Montpellier
2025-03-21
Recruiting
Medtronic MiniMed, Inc.
Not applicable
40
Bordeaux, Corbeil-Essonnes, Lille, Montpellier, Nancy, Toulouse, Dijon, Marseille
2025-03-21
Recruiting
Daiichi Sankyo
Phase 3
582
Bordeaux, Dijon, Lille, Lyon, Montpellier, Nantes, Paris, Rennes
2025-03-19
Active, closed
Celgene
Phase 3
960
Nice, Dijon, Toulouse, Vandœuvre-lès-Nancy, Pierre-Bénite, Le Mans, Villejuif, Clermont-Ferrand
2025-03-13
Recruiting
UNICANCER
Phase 2
220
Amiens, Avignon, Bayonne, Besançon, Bordeaux, Caen, Dijon, La Roche-sur-Yon
2025-03-11
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 1
60
Besançon, Dijon, Nancy, Strasbourg
2025-03-11
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Dijon, Bordeaux, Rouen, Suresnes, Paris
2025-03-11
Recruiting
Societe Francaise de Rhumatologie
Not applicable
112
Créteil, Dijon, Grenoble, Lomme, Marseille, Nice, Nîmes, Paris
2025-03-10
Recruiting
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
NCT06798922Oral Cavity Carcinoma, Flap, Radiotherapy, Adjuvant, Reconstruction Surgery
Centre Francois Baclesse
Phase 3
348
Amiens, Angers, Avranches, Caen, Cherbourg, Clermont-Ferrand, Créteil, Dijon
2025-03-01
Not yet open
University Hospital, Brest
Not applicable
252
Angers, Argeles, Aulnay-sous-Bois, Basse-Goulaine, Concarneau, Dijon, Gouesnou, Grenoble
2025-03-01
Recruiting
AstraZeneca
Phase 3
840
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Marseille, Poitiers, Rennes
2025-03-01
Recruiting
Takeda
Phase 3
171
Dijon, Créteil
2025-02-27
Recruiting
Daiichi Sankyo
Phase 3
726
Avignon, Brest, Dijon, Grenoble, Lille, Lyon, Montpellier, Nantes
2025-02-27
Recruiting
Medical University of Vienna
Observational
500
Dijon
2025-02-25
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
143
Dijon
2025-02-25
Recruiting
The Lymphoma Academic Research Organisation
Phase 2
100
Créteil, Dijon, Lille, Marseille, Montpellier, Nantes, Pierre-Bénite, Reims
2025-02-21
Recruiting
Centre Leon Berard
Phase 3
266
Le Puy-en-Velay, Pierre-Bénite, Dijon, Romans-sur-Isère, Valence, Brest, Pessac, Metz-Tessy
2025-02-21
Recruiting
Centre Hospitalier Universitaire de Besancon
Not applicable
700
Besançon, Dijon
2025-02-10
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 3
68
Dijon
2025-02-06
Recruiting
LEOPARD Training and Validation Data Collection Study
NCT06675604Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
4,500
Besançon, Chambray-lès-Tours, Clichy, Créteil, Dijon, Lille, Lyon, Marseille
2025-02-04
Not yet open
Institut Cancerologie de l'Ouest
Phase 2
114
Caen, Dijon, Lille, Limoges, Marseille, Montpellier, Paris, Pierre-Bénite
2025-02
Recruiting
Bristol-Myers Squibb
Observational
350
Amiens, Angers, Argenteuil, Arras, Bordeaux, Chalon-sur-Saône, Clermont-Ferrand, Dijon
2025-01-29
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Bordeaux, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse, Villejuif
2025-01-29
Recruiting
UNICANCER
Phase 2
198
Angers, Besançon, Bordeaux, Caen, Clermont-Ferrand, Dijon, Limoges, Lyon
2025-01-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Nice, La Rochelle, Dijon, La Tronche, Limoges, Metz, Dunkirk, Clermont-Ferrand
2025-01-27
Recruiting
BeOne Medicines
Phase 1/2
258
Dijon, Montpellier, Toulouse
2025-01-23
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
100
Dijon
2025-01-21
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
290
Bordeaux, Boulogne-Billancourt, Brest, Cergy-Pontoise, Créteil, Dijon, Lyon, Marseille
2025-01-20
Not yet open
University Hospital, Bordeaux
Not applicable
252
Bordeaux, Boulogne-Billancourt, Castelnau-le-Lez, Dijon, Grenoble, Lyon, Nice, Paris
2025-01-15
Recruiting
MED-EL Elektromedizinische Geräte GmbH
Not applicable
22
Dijon
2025-01-15
Recruiting
University Hospital, Strasbourg, France
Phase 3
110
Strasbourg, Besançon, Dijon, Reims
2025-01-08
Recruiting
Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease
NCT06987461Bronchial Dilatation Disease, Bronchectasie
Centre Hospitalier Intercommunal Creteil
Observational
70
Créteil, Dijon, Rennes, Toulouse
2025-01-06
Active, closed
Daiichi Sankyo
Phase 2
335
Caen, Dijon, Lille, Lyon, Paris, Plérin, Saint-Herblain, Toulouse
2025-01-06
Not yet open
University Hospital, Strasbourg, France
Phase 3
200
Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Gonesse, La Tronche, Lille
2025-01
Recruiting
UNICANCER
Phase 2
354
Amiens, Avignon, Bayonne, Bordeaux, Caen, Clermont-Ferrand, Dijon, Levallois-Perret
2024-12-27
Recruiting
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
NCT03593317Arrhythmogenic Right Ventricular Dysplasia
DrugSpironolactone
Hospices Civils de Lyon
Phase 2
120
Amiens, Bron, Clermont-Ferrand, Dijon, Grenoble, Marseille, Montpellier, Nantes
2024-12-20
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 3
260
Amiens, Bobigny, Bondy, Colombes, Corbeil-Essonnes, Créteil, Dijon, La Roche-sur-Yon
2024-12-17
Recruiting
Central Hospital, Nancy, France
Phase 3
164
Ars-Laquenexy, Besançon, Dijon, Lille, Reims, Strasbourg, Vandœuvre-lès-Nancy
2024-12-16
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 3
110
Dijon
2024-12-16
Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
NCT06747585Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma
Alentis Therapeutics AG
Phase 1/2
170
Bordeaux, Dijon, Lille, Marseille, Toulouse, Villejuif
2024-12-16
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Dijon, Lille, Lyon, Poitiers, Villejuif
2024-12-13
Recruiting
Hospices Civils de Lyon
Not applicable
722
Bron, Dijon, Montpellier, Nancy, Paris, Pessac, Rennes, Saint-Herblain
2024-12-12
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
360
Dijon
2024-12-11
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
210
Dijon
2024-12-11
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
270
Dijon
2024-12-10
Recruiting
Nosocomial Respiratory Virus Infection
NCT06643039Nosocomial Infections
DrugNasopharyngeal swab
Hospices Civils de Lyon
Not applicable
1,000
Bordeaux, Dijon, Lyon, Paris
2024-12-05
Recruiting
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
NCT06392997Gynecologic Disease, Gynecologic Cancer, Endometriosis, Ovarian Cancer
ZIWIG
Observational
2,500
Angers, Bordeaux, Caen, Dijon, Lyon, Neuilly-sur-Seine, Rennes, Rouen
2024-12-05
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Bordeau, Bordeaux, Dijon, Limoges, Lyon, Marseille, Paris, Plérin
2024-12-05
Active, closed
Janssen Research & Development, LLC
Phase 3
655
Brest, Dijon, Le Kremlin-Bicêtre, Lille, Montpellier, Saint-Priest-en-Jarez, Strasbourg, Talence
2024-12-04
Recruiting
University Hospital Freiburg
Not applicable
20,000
Dijon
2024-12-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Dijon, Saint Priest En Jarez, Pierre-Bénite, Paris
2024-12-02
Recruiting
ADDICTOlogical Intervention in LIVEr Transplantation Recipients
NCT06472973Alcohol Associated Liver Disease, Liver Transplantation
University Hospital, Montpellier
Not applicable
720
Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier
2024-11-21
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Angers, Bordeaux, Caen, Dijon, Montpellier, Nantes, Paris, Rennes
2024-11-15
Recruiting
Centre Leon Berard
Not applicable
100
Angers, Bourg-en-Bresse, Dijon, Grenoble, Lyon, Marseille, Nice, Saint-Herblain
2024-11-15
Recruiting
Genentech, Inc.
Phase 1
410
Villejuif, Bordeaux, Dijon
2024-11-14
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
52
Dijon
2024-11-13
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Amiens, Angers, Clichy, Créteil, Dijon, Le Chesnay, Lille, Lyon
2024-11-12
Recruiting
EkiYou-Study-2 : A National Multicentric Trial of the EkiYou Application for Insulin Bolus Calculation
NCT06738849Diabetes Type 1, Diabetes Type 2 on Insulin, Pancreatogenous Diabetes
DiappyMed
Not applicable
154
Bobigny, Caen, Chartres, Corbeil-Essonnes, Dijon, Le Havre, Limoges, Marseille
2024-11-05
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Nice, Marseille, Poitiers, Toulouse, Créteil, Dijon, Lille, Lyon
2024-10-30
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
1,020
Amiens, Angers, Besançon, Bordeaux, Brest, Corbeil-Essonnes, Dijon, Grenoble
2024-10-30
Recruiting
Abivax S.A.
Phase 2
212
Amiens, Besançon, Clermont-Ferrand, Créteil, Dijon, Grenoble, La Roche-sur-Yon, Le Kremlin-Bicêtre
2024-10-30
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Bordeaux, Dijon, Lille, Lyon, Montpellier, Paris, Rennes, Strasbourg
2024-10-29
Recruiting
Vulnerability and Risk of Neuropathic Pain in Cancer
NCT06511674Neuropathic Pain, Cancer, Predictive
University Hospital, Clermont-Ferrand
Not applicable
625
Ajaccio, Angers, Aurillac, Bordeaux, Caen, Clermont-Ferrand, Colmar, Dijon
2024-10-28
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 1/2
48
Dijon
2024-10-21
Recruiting
argenx
Phase 3
69
Amiens, Créteil, Dijon
2024-10-18
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Amiens, Angers, Clichy, Créteil, Dijon, Le Chesnay, Lille, Lyon
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 2
588
Bordeaux, Dijon, Lyon, Marseille, Poitiers, Villejuif
2024-10-11
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
78
Dijon
2024-10-10
Active, closed
Novartis Pharmaceuticals
Phase 2
201
Dijon, Le Mans, Lille, Montpellier, Paris, Rennes, Strasbourg, Toulouse
2024-10-09
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Dijon, Brest, Toulouse, Montpellier, Rennes, Vandœuvre-lès-Nancy, Lille, Le Mans
2024-10-07
Not yet open
University Hospital, Strasbourg, France
Not applicable
448
Dijon, Mulhouse, Nancy, Strasbourg
2024-10
Recruiting
Institut de Cancérologie de Lorraine
Not applicable
188
Caen, Vandœuvre-lès-Nancy, Besançon, Dijon, Reims, Strasbourg
2024-09-30
Not yet open
Pr. Nicolas GIRERD
Observational
89,700
Besançon, Dijon, Lyon, Nancy
2024-09-30
Recruiting
Mean Arterial Pressure After Out-of-hospital Cardiac Arrest
NCT05486884Cardiac Arrest, Out-of-hospital Cardiac Arrest (OHCA)
Centre Hospitalier le Mans
Not applicable
1,380
Montpellier, Brest, Brive-la-Gaillarde, Caen, Cannes, Cholet, Dieppe, Dijon
2024-09-28
Recruiting
Egle Therapeutics
Phase 1/2
50
Dijon, Montpellier, Paris
2024-09-27
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Angers, Bobigny, Brest, Bron, Caen, Dijon, La Tronche, Le Kremlin-Bicêtre
2024-09-26
Recruiting
Hospices Civils de Lyon
Not applicable
500
Dijon, Lyon, Nantes, Pierre-Bénite
2024-09-25
Recruiting
Hospices Civils de Lyon
Observational
50
Amiens, Bron, Clermont-Ferrand, Creil, Dijon, Lyon, Paris, Pierre-Bénite
2024-09-24
Recruiting
Study of Cancer Patients' Preferences for Genetic Information Modalities Preceding Theranostic Exome Analysis.
NCT06550687All Types of Metastatic Solid Malignancy, 1st-line Treatment, Exome Analysis, Active File EXOMA2 Study
Centre Georges Francois Leclerc
Not applicable
80
Dijon
2024-09-19
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Pierre-Bénite, Dijon, Tours, Bordeaux, La Tronche, Poitiers, Caen, Nantes
2024-09-18
Active, closed
Hoffmann-La Roche
Phase 3
400
Amiens, Dijon, La Roche-sur-Yon, Lille, Marseille, Neuilly-sur-Seine, Nice, Pessac
2024-09-17
Recruiting
UNICANCER
Phase 3
500
Angers, Bordeaux, Brest, Caen, Créteil, Dijon, Grenoble, Lyon
2024-09-12
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
308
Dijon
2024-09-11
Recruiting
Oncology, Undernutrition and Sensoriality: Links, Mechanisms and Levers for Action
NCT06600295Oropharynx Cancer, Oral Cavity, Colon Cancer, Liver Cancer
DrugBiological samples
Centre Hospitalier Universitaire Dijon
Observational
306
Dijon
2024-09-06
Recruiting
POlycythemia, Proteins and ErYthropoiesis
NCT06905106Erythropoiesis
Centre Hospitalier Universitaire Dijon
Observational
400
Dijon
2024-09-01
Not yet open
Pharmacokinetics and Modelling of Beta-Lactam in ECMO-VA Patients
NCT06338345Cardiogenic Shock, Post-cardiac Surgery, Cardiac Arrest, Extracorporeal Membrane Oxygenation Complication
University Hospital, Grenoble
Not applicable
225
Clermont-Ferrand, Dijon, Paris, Rouen, Toulouse
2024-09-01
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
48
Bordeaux, Dijon, Lille, Saint-Cloud, Saint-Herblain, Vandœuvre-lès-Nancy
2024-08-31
Active, closed
Microbiotica Ltd
Phase 1
41
Dijon, Lille, Lyon, Marseille, Pierre-Bénite
2024-08-28
Recruiting
Study of the Pathophysiology of RNU4ATAC and RTTN Associated Syndromes
NCT06111950Taybi Linder Syndrome, Microcephalic Osteodysplastic Primordial Dwarfism Types I and III, Roifman Syndrome, Lowry Wood Syndrome
Hospices Civils de Lyon
Not applicable
45
Bordeaux, Bron, Dijon, Lille, Paris, Rennes
2024-08-27
Active, closed
AstraZeneca
Phase 2
194
Bois-Guillaume, Caen, Dijon, Montpellier
2024-08-27
Recruiting
Jazz Pharmaceuticals
Phase 3
550
Bordeaux, Caen, Dijon, Le Mans, Lille, Marseille, Montpellier, Strasbourg
2024-08-13
Recruiting
AstraZeneca
Phase 3
620
Brest, Clichy, Dijon, Lille, Lyon, Marseille, Montpellier, Pessac
2024-08-12
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
360
Dijon
2024-08-08
Active, closed
EyeBiotech Ltd.
Phase 2/3
984
Dijon, Créteil, Lyon, Marseille, Paris, Saint-Cyr-sur-Loire
2024-08-07
Active, closed
Pfizer
Observational
450
Bordeaux, Argenteuil, Caen, Dijon, La Tronche, Lille, Rennes, Rouen
2024-08-07
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
102
Dijon, Grenoble, Marseille, Saint-Herblain, Villejuif
2024-08-07
Active, closed
Iptacopan in Patients With ANCA Associated Vasculitis
NCT06388941Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
DrugsIptacopan·Rituximab
Novartis Pharmaceuticals
Phase 2
84
Angers, Brest, Dijon, Marseille, Paris, Toulouse
2024-08-05
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Angers, Bayonne, Bordeaux, Caen, Dijon, Le Mans, Lille, Lyon
2024-07-31
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Strasbourg, Dijon, Toulouse, Montpellier, Tours, Nancy, Lille, Lyon
2024-07-30
Active, closed
Annexon, Inc.
Phase 3
659
Bordeaux, Créteil, Dijon, Écully, Marseille, Nice, Paris, Strasbourg
2024-07-30
Recruiting
Hospices Civils de Lyon
Phase 4
140
Avignon, Bobigny, Créteil, Dijon, Lille, Limoges, Lyon, Montpellier
2024-07-30
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
40
Dijon
2024-07-29
Recruiting
LAnguage-Motor Imagery Circuits to Improve Motor Learning and Language Comprehension
NCT06478303Corticospinal Excitability, Cortical Activation
University Hospital, Grenoble
Observational
105
Grenoble, Dijon
2024-07-27
Recruiting
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
NCT06333314Pancreatic Adenocarcinoma, Ampulla of Vater Carcinoma, Adrenocortical Carcinoma, Neuroendocrine Carcinoma
DrugDostarlimab
UNICANCER
Phase 2
120
Angers, Avignon, Besançon, Brest, Caen, Clermont-Ferrand, Créteil, Dijon
2024-07-23
Recruiting
CellProthera
Observational
48
Mulhouse, Dijon, Massy, Montpellier, Pessac, Toulouse
2024-07-20
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2
174
Auxerre, Besançon, Colmar, Dijon, Metz, Montbéliard, Montpellier, Reims
2024-07-19
Recruiting
Amgen
Phase 3
450
Clermont-Ferrand, Créteil, Dijon, Lyon, Montpellier, Nice, Paris, Pessac
2024-07-17
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Nancy, Saint-Herblain, Bordeaux, Limoges, Boulogne-Billancourt, Dijon, Nantes, Vantoux
2024-07-16
Active, closed
Cardiovascular and Interventional Radiological Society of Europe
Observational
400
Dijon, Paris, Strasbourg
2024-07-15
Recruiting
Hopital Forcilles
Observational
114
Beuvry, Dijon, Lyon, Férolles-Attilly
2024-07-09
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
40
Dijon
2024-07-01
Active, closed
AstraZeneca
Phase 3
339
Bois-Guillaume, Dijon, Lyon, Montivilliers, Nantes, Paris, Poitiers, Toulouse
2024-06-29
Active, closed
Novartis Pharmaceuticals
Phase 3
162
Toulon, Brest, Cholet, Colmar, Dijon, Le Mans, Nantes, Reims
2024-06-28
Active, closed
Nantes University Hospital
Phase 2
103
Bayonne, Caen, Dijon, La Roche-sur-Yon, Lille, Limoges, Lyon, Marseille
2024-06-26
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
554
Albi, Angers, Besançon, Carcassonne, Dijon, Grenoble, Limoges, Lyon
2024-06-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Nice, Bayonne, Guilherand-Granges, Lyon Cedex08, Clermont-Ferrand, Marseille, Caen, Dijon
2024-06-24
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicable
72
Dijon, Grenoble, Lille, Marseille, Reims, Rouen, Saint-Cloud, Saint-Herblain
2024-06-24
Recruiting
REmote COnditioning in Out-of-Hospital Cardiac Arrest
NCT06306625Out-Of-Hospital Cardiac Arrest
Hospices Civils de Lyon
Not applicable
220
Bron, Clermont-Ferrand, Dijon, La Tronche, Lyon, Marseille, Montpellier, Nîmes
2024-06-21
Active, closed
Celgene
Phase 3
850
Nice, Strasbourg, Bordeaux, Pessac, Marseille, Dijon, Besançon, Brest
2024-06-19
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
5,000
Dijon
2024-06-19
Active, closed
Novartis Pharmaceuticals
Observational
192
Nice, Antony, Bordeaux, Brest, Calais, Dijon, La Rochelle, Le Mans
2024-06-17
Recruiting
Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
NCT06271057Diffuse Large B-cell Lymphoma Refractory, Refractory Primary Mediastinal Large B-Cell Lymphoma, Refractory Transformed B-cell Non-Hodgkin Lymphoma, Refractory High Grade B-Cell Lymphoma
DrugGolcadomide
The Lymphoma Academic Research Organisation
Phase 2
65
Créteil, Dijon, La Tronche, Lille, Marseille, Montpellier, Nantes, Paris
2024-06-14
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
297
Dijon
2024-06-13
Recruiting
Centre Georges Francois Leclerc
Observational
150
Dijon, Levallois-Perret
2024-06-12
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 3
150
Dijon
2024-06-07
Active, closed
Exelixis
Phase 2/3
600
Marseille, Bordeaux, Rennes, Saint Priest En Jarez, Lyon, Le Mans, Villejuif, Dijon
2024-06-07
Recruiting
DVT Burden and the Risk of Post-thrombotic Syndrome
NCT06385353Postthrombotic Syndrome
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Not applicable
400
Vichy, Carcassonne, Aubagne, Marseille, Martigues, Ajaccio, Dijon, Besançon
2024-06-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Nice, Pessac, Marseille, Dijon, Reims, Besançon, Valence, Nîmes
2024-06-05
Recruiting
Immunocore Ltd
Phase 3
680
Marseille, Toulouse, Bobigny, Boulogne-Billancourt, Caen, Dijon, Lille, Nantes
2024-06-05
Recruiting
Structural and Microbiological Characterization of Arterial Catheter Biofilm in ICU's Patients Using Optical Coherence Tomography
NCT06838598Biofilms, Arterial Catheterization, Peripheral, Bacteremia, Tomography, Optical Coherence
Centre Hospitalier William Morey - Chalon sur Saône
Observational
60
Dijon, Mâcon
2024-06-03
Not yet open
Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis
NCT05473403Liver Failure, Acute, Hepatitis, Autoimmune, Organ Dysfunction Scores, Risk Factors
Assistance Publique - Hôpitaux de Paris
Not applicable
150
Angers, Besançon, Bobigny, Brest, Caen, Chambray-lès-Tours, Dijon, Lille
2024-06-01
Active, closed
Amgen
Phase 1
120
Bordeaux, Dijon, Marseille, Villejuif
2024-05-29
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
66
Dijon
2024-05-27
Recruiting
Institut Curie
Phase 3
300
Bayonne, Bordeaux, Caen, Dijon, Lille, Limoges, Lyon, Marseille
2024-05-27
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Amiens, Clichy, Dijon, Limoges, Lyon, Montpellier, Nice, Paris
2024-05-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Nice, Dijon, Nîmes, Valenciennes, Clermont-Ferrand, Avignon, Boulogne-Billancourt
2024-05-24
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
NCT06237452Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
Phase 3
852
Les Paris, Dijon, Paris, Bordeaux Cedex, Garches, Nantes, Lyon, Tours
2024-05-20
Active, closed
Novartis Pharmaceuticals
Phase 1
42
Dijon
2024-05-15
Active, closed
Centre Hospitalier Universitaire Dijon
Phase 3
120
Dijon
2024-05-13
Recruiting
University Hospital, Rouen
Phase 3
232
Amiens, Beauvais, Besançon, Bobigny, Caen, Clamart, Colmar, Dijon
2024-05-07
Recruiting
University Hospital, Limoges
Not applicable
244
Bordeaux, Brest, Bron, Dijon, Grenoble, Lille, Limoges, Marseille
2024-05-06
Active, closed
Servier Bio-Innovation LLC
Phase 1/2
61
Bordeaux, Dijon
2024-04-29
Active, closed
Erasca, Inc.
Phase 3
78
Bordeaux, Dijon, Le Mans, Lille, Lyon, Marseille, Paris, Villejuif
2024-04-29
Recruiting
Centre Hospitalier Princesse Grace
Observational
1,500
Angers, Clermont-Ferrand, Dijon, Grenoble, Lyon, Montpellier, Nantes, Nice
2024-04-19
Recruiting
AstraZeneca
Phase 3
3,850
Béziers, Bron, Caen, Cholet, Créteil, Dijon, La Roche-sur-Yon, La Tronche
2024-04-12
Recruiting
Daiichi Sankyo
Phase 1/2
680
Dijon, Bordeaux, Montpellier, Rennes, Saint-Herblain, Paris, Lyon, Villejuif
2024-04-10
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
556
Dijon
2024-04-08
Recruiting
UNICANCER
Phase 2
420
Saint-Denis, Avignon, Dijon, Lille, Marseille, Nice, Nîmes, Paris
2024-04-03
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
60
Dijon
2024-04-03
Recruiting
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
NCT07699328EGFR-Mutant Non-Small Cell Lung Cancer
Voronoi, Inc
Phase 1/2
315
Marseille, Dijon
2024-03-26
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
NCT06253871HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer, HER2 + Breast Cancer
Iambic Therapeutics, Inc
Phase 1
383
Dijon, Saint-Herblain, Toulouse
2024-03-25
Recruiting
GlaxoSmithKline
Phase 3
864
Ars-Laquenexy, Caen, Dijon, Marseille, Poitiers, Quimper, Rennes, Rouen
2024-03-21
Recruiting
Verastem, Inc.
Phase 3
270
Besançon, Dijon, Lille, Lyon, Paris
2024-03-18
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
100
Dijon
2024-03-15
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Strasbourg, Dijon, Toulouse, Montpellier, Tours, Nancy, Lille, Lyon
2024-03-14
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bobigny, Bron, Chambray-lès-Tours, Compiègne, Dijon, Le Coudray, Lille, Lyon
2024-03-05
Recruiting
University Hospital, Strasbourg, France
Not applicable
150
Besançon, Bordeaux, Caen, Dijon, Lyon, Marseille, Nantes, Nice
2024-03-04
Recruiting
Daiichi Sankyo
Phase 2/3
860
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Marseille, Montpellier, Nantes
2024-02-27
Active, closed
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer
NCT06239467Advanced Cancer, Breast Cancer, Advanced Solid Tumors, PI3K Gene Mutation
DrugsAtirmociclib·Tucatinib·Ribociclib·Fulvestrant
OnKure, Inc.
Phase 1
200
Dijon, Lille, Lyon, Nice, Pierre-Bénite, Villejuif
2024-02-26
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Toulouse, Vandœuvre-lès-Nancy
2024-02-26
Active, closed
AbbVie
Observational
1,200
Nice, Clermont, Lyon, Marseille, Dijon, Pessac, Toulouse, Montpellier
2024-02-19
Recruiting
Treatment Resistant Depression and Vagus Nerve Stimulation
NCT05952674Treatment Resistant Depression (TRD)
Assistance Publique - Hôpitaux de Paris
Not applicable
166
Angers, Bordeaux, Caen, Clermont-Ferrand, Colombes, Créteil, Dijon, Grenoble
2024-02-19
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 2
130
Dijon
2024-02-16
Recruiting
Centre Francois Baclesse
Not applicable
300
Bordeaux, Briis-sous-Forges, Caen, Chambéry, Clermont-Ferrand, Dijon, Grenoble, Limoges
2024-02-09
Recruiting
Evaluation of Integrated Versus Parallel Connection for Renal Replacement Therapy in ECMO Patients
NCT06038162Venoarterial Extracorporeal Membrane Oxygenation, Renal Replacement Therapy, Acute Kidney Injury
Hospices Civils de Lyon
Not applicable
158
Bordeaux, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon, Montpellier, Paris
2024-02-07
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
100
Dijon
2024-01-31
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
80
Dijon
2024-01-31
Active, closed
Incyte Corporation
Phase 3
617
Bordeaux, Brest, Dijon, Le Mans, Lyon, Marseille, Nantes, Nice
2024-01-30
Recruiting
University Hospital, Angers
Not applicable
630
Amiens, Angers, Brest, Chambray-lès-Tours, Château-Gontier, Dijon, Grenoble, La Roche-sur-Yon
2024-01-30
Recruiting
Association Francaise pour la Recherche Thermale
Not applicable
110
Bordeaux, Créteil, Dijon, Grenoble, Levallois-Perret, Marseille, Mougins, Rennes
2024-01-29
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
150
Dijon
2024-01-25
Recruiting
Centre Georges Francois Leclerc
Phase 2
90
Dijon
2024-01-24
Recruiting
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
NCT06137144Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Peripheral T-cell Lymphoma (PTCL)
DrugsAZD3470·Keytruda·Pembrolizumab
AstraZeneca
Phase 1/2
161
Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
2024-01-23
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Bron, Dijon, Lille, Paris, Toulouse
2024-01-19
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
NCT06162221Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer, Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
DrugsElironrasib·RMC-9805·Cetuximab·Pemetrexed
Revolution Medicines, Inc.
Phase 1/2
616
Bron, Dijon, Lille, Nantes, Bordeaux, Angers, Boulogne, Caen
2024-01-18
Recruiting
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
NCT06247826Non-small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
Groupe Francais De Pneumo-Cancerologie
Not applicable
30
Bordeaux, Brest, Créteil, Dijon, Grenoble, Le Mans, Marseille, Nice
2024-01-15
Recruiting
NovoCure Ltd.
Observational
430
Amiens, Avignon, Bordeaux, Brest, Bron, Caen, Clermont-Ferrand, Dijon
2024-01-11
Recruiting
University Hospital, Angers
Not applicable
500
Angers, Bordeaux, Brest, Créteil, Dijon, Grenoble, Le Mans, Nancy
2024-01-09
Active, closed
University Hospital, Lille
Phase 2
74
Amiens, Angers, Avignon, Bayonne, Besançon, Caen, Dijon, La Tronche
2023-12-21
Active, closed
Bristol-Myers Squibb
Phase 3
190
Strasbourg, Pessac, Dijon, Rouen, La Tronche, Saint-Herblain, Pierre-Bénite, Paris
2023-12-21
Recruiting
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
NCT05581121Cervical Carcinoma, Adenocarcinoma, Adenosquamous Carcinoma
Institut Claudius Regaud
Phase 3
510
Angers, Bordeaux, Brest, Caen, Créteil, Dijon, Lille, Limoges
2023-12-20
Recruiting
Institut Curie
Phase 2
66
Clermont-Ferrand, Amiens, Avignon, Caen, Dijon, Lille, Montpellier, Nantes
2023-12-19
Recruiting
Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
NCT05800275Leptomeningeal Metastasis, Leptomeningeal Disease, HER2-positive Metastatic Breast Cancer
DrugsTucatinib·Trastuzumab·Capecitabine
UNICANCER
Phase 2
30
Bordeaux, Caen, Clermont-Ferrand, Dijon, Lyon, Montpellier, Nice, Reims
2023-12-18
Recruiting
Hospices Civils de Lyon
Not applicable
250
Ajaccio, Amiens, Bron, Caen, Dijon, Le Plessis-Robinson, Lille, Lyon
2023-12-15
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Bayonne, Beuvry, Boulogne-sur-Mer, Bron, Calais, Chambray-lès-Tours, Dechy, Dijon
2023-12-15
Recruiting
Centre Hospitalier St Anne
Phase 3
500
Brest, Caen, Clermont-Ferrand, Dijon, Lille, Montpellier, Nancy, Orsay
2023-12-15
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
54
Dijon, Rennes, Bordeaux, Lyon, Villejuif
2023-12-13
Active, closed
Syndax Pharmaceuticals
Phase 2
145
Amiens, Brest, Dijon, Rennes
2023-12-11
Recruiting
Institut Claudius Regaud
Not applicable
150
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Grenoble, Lille, Lyon
2023-12-07
Recruiting
Centre Hospitalier de Bethune
Not applicable
48
Béthune, Caen, Dijon, Nancy, Rouen
2023-12-07
Recruiting
Novartis Pharmaceuticals
Phase 2/3
232
Angers, Bordeaux, Bron, Caen, Dijon, Lille, Marseille, Montpellier
2023-11-24
Recruiting
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673Alzheimer's Disease Psychosis
DrugACP-204
ACADIA Pharmaceuticals Inc.
Phase 2/3
1,074
Bron, Colmar, Dijon, Limoges, Lyon, Paris, Rouen, Toulouse
2023-11-14
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
100
Dijon
2023-11-09
Active, closed
Novartis Pharmaceuticals
Phase 1
33
Dijon, Clermont-Ferrand, Lyon, Nantes, Saint-Herblain, Vandœuvre-lès-Nancy
2023-11-07
Recruiting
Institut Curie
Not applicable
600
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2023-11-02
Active, closed
Influence of Food Preferences on the Occurrence of Undernutrition in Treated Patients for Bronchopulmonary Carcinoma Non-small Cell Stage IV
NCT05496556Non-small Cell Bronchopulmonary Carcinoma at Stage IV and Benefiting From First-line Treatment According to Current French Recommendations
Centre Georges Francois Leclerc
Not applicable
190
Dijon
2023-11-01
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Angers, Brest, Dijon, Le Kremlin-Bicêtre, Le Mans, Lille, Paris, Saint-Priest-en-Jarez
2023-10-27
Recruiting
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
170
Dijon, Bourdeaux, Lille, Lyon, Marseille, Montpellier, Nantes, Paris
2023-10-27
Recruiting
Fondation Hôpital Saint-Joseph
Phase 3
110
Angers, Besançon, Bobigny, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon
2023-10-26
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Bron, Grenoble, Angers, Nantes, Marseille, Bobigny, Brest, Dijon
2023-10-25
Recruiting
A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
NCT05946564ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic Glomerulonephritis
DrugPioglitazone
Assistance Publique - Hôpitaux de Paris
Phase 3
126
Amiens, Angers, Boulogne-sur-Mer, Brest, Dijon, Grenoble, La Roche-sur-Yon, Le Kremlin-Bicêtre
2023-10-24
Recruiting
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
NCT05879757Multiple Myeloma, Secondary Immunodeficiency (SID)
Takeda
Observational
75
Salouël, Dijon, Nantes, Orléans, Pessac
2023-10-17
Recruiting
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
NCT05783908Patient With Radiotherapy (Linac MRI), Mobile Cancerous Lesion
Centre Georges Francois Leclerc
Not applicable
100
Dijon
2023-10-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Grenoble, Chambray-lès-Tours, Orléans, Dijon, Le Coudray, Nîmes, Limoges, Rennes
2023-10-09
Active, closed
AstraZeneca
Phase 3
5,511
Angers, Bordeaux, Caen, Clermont-Ferrand, Dijon, Epagny Metz-Tessy, Lille, Lyon
2023-10-05
Not yet open
Knowing and Treating Kosaki/Penttinen Syndromes
NCT05953857Kosaki Overgrowth Syndrome, Penttinen Syndrome
Centre Hospitalier Universitaire Dijon
Observational
30
Dijon
2023-10
Active, closed
Asten Sante
Not applicable
556
La Roche-sur-Yon, Paris, Angers, Dijon, Le Chesnay, Le Mans, Nancy, Rennes
2023-09-29
Recruiting
University Hospital, Toulouse
Not applicable
100
Amiens, Caen, Dijon, Epagny Metz- Tessy, Lille, Lyon, Montpellier, Paris
2023-09-28
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
56
Dijon
2023-09-26
Recruiting
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
NCT05699005Cardiogenic Shock, Extracorporeal Membrane Oxygenation, Transfusion Related Complication, Anemia
University Hospital, Lille
Phase 1
236
Lille, Amiens, Dijon
2023-09-18
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Bron, Grenoble, Nantes, Marseille, Angers, Bobigny, Brest, Dijon
2023-09-14
Recruiting
Hoffmann-La Roche
Phase 3
230
Avignon, Bayonne, Bordeaux, Dijon, Lille
2023-09-08
Active, closed
RegenLab France SAS
Not applicable
280
Dijon, Corbeil-Essonnes, Créteil, La Roche-sur-Yon, Limoges, Lyon, Montpellier, Nantes
2023-08-21
Recruiting
Centre Hospitalier de Lens
Observational
200
Béthune, Boulogne-sur-Mer, Dijon, Lens, Lille
2023-08-21
Active, closed
AstraZeneca
Phase 3
142
Clichy, Dijon, Montpellier, Villejuif
2023-08-16
Recruiting
Centre Hospitalier Universitaire de Saint Etienne
Phase 3
1,400
Amiens, Angers, Besançon, Brest, Castelnau-le-Lez, Clermont-Ferrand, Dijon, Firminy
2023-08-16
Active, closed
The BD Liverty™ TIPS Stent Graft Study
NCT05711316Portal Hypertension, TIPS
C. R. Bard
Not applicable
177
Chambray-lès-Tours, Dijon, Lyon
2023-08-08
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
101
Dijon
2023-08-07
Recruiting
Centre Leon Berard
Not applicable
166
Nantes, Lyon, Angers, Bordeaux, Chambray-lès-Tours, Clermont-Ferrand, Dijon, Lille
2023-08-03
Recruiting
University Hospital, Toulouse
Phase 3
1,164
Angers, Bordeaux, Clermont-Ferrand, Dijon, Lille, Lyon, Marseille, Montpellier
2023-08-02
Active, closed
Belite Bio, Inc
Phase 3
429
Dijon, Écully, Lyon, Marseille
2023-07-27
Recruiting
Nantes University Hospital
Observational
700
Besançon, Brest, Angers, Blois, Bordeaux, Dijon, Grenoble, La Rochelle
2023-07-24
Active, closed
Eagle Pharmaceuticals, Inc.
Phase 2
276
La Roche-sur-Yon, Angers, Argenteuil, Belfort, Bourg-en-Bresse, Dieppe, Dijon, Garches
2023-07-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Nice, Marseille, Dijon, Besançon, Bordeaux, Rennes, Lille, Pierre-Bénite
2023-07-19
Active, closed
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
NCT06094127Thoracic Aortic Aneurysm, Penetrating Aortic Ulcer
Cook Research Incorporated
Observational
300
Dijon, Le Plessis-Robinson, Lille
2023-07-06
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
120
Dijon
2023-07-06
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 3
390
Dijon
2023-07-03
Recruiting
Pr Bruno LEVY
Phase 3
610
Strasbourg, Marseille, Caen, Dijon, Besançon, Nîmes, Bordeaux, Toulouse
2023-07-03
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
390
Bordeaux, Dijon, Toulouse, Pierre-Bénite, Paris
2023-06-23
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
140
Dijon
2023-06-13
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
74
Dijon
2023-06-12
Recruiting
Hoffmann-La Roche
Phase 3
100
Marseille, Bordeaux, Caen, Dijon, Lyon, Montpellier, Nantes, Nîmes
2023-06-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
500
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon
2023-05-31
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
50
Dijon
2023-05-16
Recruiting
Centre Hospitalier Universitaire de Besancon
Phase 2/3
446
Besançon, Clermont-Ferrand, Créteil, Dijon, Lyon, Montbéliard, Montpellier, Mulhouse
2023-05-09
Active, closed
Gilead Sciences
Phase 3
654
Besançon, Bordeaux, Dijon, Lille, Limoges, Loire Atlantique, Lyon, Marseille
2023-05-08
Active, closed
CEN Biotech
Observational
239
Dijon, Lille, Orléans, Saint-Priest-en-Jarez
2023-05-05
Recruiting
The Ailliance Post-Market Clinical Study
NCT05856370Spinal Deformity, Spinal Degenerative Disorder, Spinal Fusion Failure, Spinal Trauma
Medtronic Spinal and Biologics
Not applicable
1,000
Dijon, Lille
2023-05-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
600
Angers, Bron, Caen, Chambray-lès-Tours, Dijon, Grenoble, Lille, Montpellier
2023-04-28
Recruiting
ANRS, Emerging Infectious Diseases
Phase 2
256
Bordeaux, Dijon, Lyon, Montpellier, Nantes, Paris, Reims, Toulouse
2023-04-27
Recruiting
Poitiers University Hospital
Not applicable
120
Angers, Brest, Caen, Dijon, Grenoble, Marseille, Poitiers, Saint-Denis
2023-04-21
Recruiting
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
NCT05786924Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, BRAF Gene Mutation
DrugsPanitumumab·Folfox·Cetuximab·Nab-paclitaxel
Institut de Recherches Internationales Servier
Phase 1/2
554
Dijon, Paris, Rennes, Villejuif
2023-04-18
Active, closed
Jazz Pharmaceuticals
Observational
158
Amiens, Angers, Bordeaux, Bron, Dijon, Grenoble, Le Kremlin-Bicêtre, Lille
2023-04-17
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Angers, Bayonne, Béziers, Brest, Bron, Corbeil-Essonnes, Créteil, Dijon
2023-04-11
Recruiting
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
NCT05641142Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease
University Hospital, Clermont-Ferrand
Not applicable
100
Angers, Bordeaux, Boulogne-Billancourt, Caen, Clermont-Ferrand, Dijon, Lille, Lyon
2023-04-07
Active, closed
Bayer
Phase 3
985
Clermont-Ferrand, La Tronche, Lyon, Pierre-Bénite, Besançon, Dijon, Brest, Rennes
2023-04-03
Recruiting
Nantes University Hospital
Phase 3
266
Besançon, Bordeaux, Brest, Clermont-Ferrand, Dijon, La Rochelle, Lyon, Montpellier
2023-03-31
Active, closed
UNICANCER
Phase 2
100
Aix-en-Provence, Avignon, Bayonne, Caen, Clermont-Ferrand, Créteil, Dijon, Lille
2023-03-24
Active, closed
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
NCT05650879HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation, HER2 Amplification
DrugsELVN-002·Fam-Trastuzumab Deruxtecan-Nxki·Trastuzumab emtansine·Trastuzumab deruxtecan
Enliven Therapeutics
Phase 1
198
Marseille, Rennes, Caen, Bordeaux, Dijon, Lyon, Villejuif
2023-03-20
Active, closed
AbbVie
Phase 3
520
Strasbourg, Marseille, Dijon, Brest, Lyon, Paris
2023-03-15
Recruiting
Lumara Bio Oncologics GmbH
Phase 1/2
270
Clermont-Ferrand, Dijon, Grenoble, Lyon, Marseille, Nantes, Toulouse, Vandœuvre-lès-Nancy
2023-03-14
Active, closed
Hospices Civils de Lyon
Phase 4
20
Besançon, Dijon, Lille, Lyon, Montpellier, Paris, Reims, Toulouse
2023-03-09
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Avignon, Besançon, Béziers, Bobigny, Bordeaux, Caen, Compiègne, Dijon
2023-03-09
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
14,500
Angers, Bordeaux, Bron, Clamart, Clermont-Ferrand, Créteil, Dijon, Lille
2023-03-06
Active, closed
Pfizer
Phase 3
624
Dijon, Montpellier, Saint-Herblain, Angers, Clermont-Ferrand, Avignon, Poitiers, Créteil
2023-03-03
Active, closed
AstraZeneca
Observational
551
Nice, Clermont-Ferrand, Strasbourg, Finist Re, Dijon, Bordeaux, Grenoble, Saint-Denis
2023-02-27
Active, closed
AbbVie
Observational
300
Saint-Quentin, Clermont, Marseille, Rennes, Dijon, Niort, Besançon, Romans-sur-Isère
2023-02-21
Recruiting
Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia
NCT04871048Schizophrenia, Cannabis-Induced Disorder
Centre Hospitalier Universitaire de Saint Etienne
Not applicable
110
Bron, Clermont-Ferrand, Dijon, La Tronche, Saint-Cyr-au-Mont-d'Or, Saint-Égrève, Saint-Priest-en-Jarez
2023-02-15
Recruiting
Centre Hospitalier Universitaire Dijon
Observational
130
Dijon
2023-02-13
Active, closed
Kite, A Gilead Company
Phase 3
300
Bordeaux, Cedex Lyon 08, Dijon, Lille, Montpellier, Nice, Paris, Rennes
2023-02-10
Active, closed
Genmab
Phase 3
900
Nice, Clermont, Marseille, Rennes, Dijon, Limoges, Montpellier, La Tronche
2023-02-08
Recruiting
Centre Hospitalier Universitaire Dijon
Not applicable
404
Dijon
2023-02-05
Active, closed
Institut de Cancérologie de Lorraine
Not applicable
136
Besançon, Dijon, Lille, Mulhouse, Reims, Vandœuvre-lès-Nancy
2023-01-31
Active, closed
University Hospital, Bordeaux
Phase 3
22
Bayonne, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Grenoble, Limoges
2023-01-23
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Nice, Reims, Marseille, Caen, Dijon, Besançon, Pessac, Toulouse
2023-01-16
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Dijon, Besançon, Bordeaux, Toulouse, Lille, Montpellier, La Tronche, Caen
2023-01-16
Recruiting
Optimisation Strategy for Emergency Tracheal Intubation
NCT05539391Emergencies, Out-of-hospital Setting, Tracheal Intubation
University Hospital, Bordeaux
Not applicable
1,500
Angers, Beaumont-sur-Oise, Bobigny, Bordeaux, Cergy-Pontoise, Créteil, Dijon, Eaubonne
2023-01-14
Active, closed
Centre Hospitalier Universitaire Dijon
Phase 3
840
Dijon
2023-01-02
Active, closed
Amgen
Phase 3
7,297
Besançon, Bron, Chambray-lès-Tours, Compiègne, Dijon, Lille, Marseille, Montpellier
2022-12-14
Active, closed
Novartis Pharmaceuticals
Observational
1,019
Nice, Marseille, Dijon, Saint-Denis, Valenciennes, Saint-Cloud, Grenoble, Reims
2022-12-13
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Bron, Dijon, Marseille, Montpellier, Paris, Saint-Herblain, Strasbourg, Valenciennes
2022-12-13
Recruiting
AstraZeneca
Phase 3
3,527
Amiens, Angers, Brest, Créteil, Dijon, La Tronche, Le Coudray, Montpellier
2022-12-13
Recruiting
Gilead Sciences
Phase 3
1,514
Amiens, Chambray-lès-Tours, Dijon, Le Mans, Limoges, Loire Atlantique, Lyon, Nancy
2022-12-12
Active, closed
Carmat SAS
Not applicable
104
Bron, Dijon, Le Plessis-Robinson, Lille, Montpellier, Nantes, Paris, Rennes
2022-12-12
Active, closed
AstraZeneca
Phase 3
1,174
Angers, Bordeaux, Dijon, Lyon, Montpellier, Nîmes, Paris, Poitiers
2022-11-28
Recruiting
Centre Hospitalier Universitaire Dijon
Phase 2
20
Amiens, Angers, Brest, Bron, Clermont-Ferrand, Dijon, Lille, Nîmes
2022-11-28
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
41
Agen, Brest, Bordeaux, Boulogne-Billancourt, Créteil, Dijon, Lille, Marseille
2022-11-25
Active, closed
Centre Georges Francois Leclerc
Not applicable
32
Dijon
2022-11-25
Active, closed
Mirati Therapeutics Inc.
Phase 2
90
Angers, Caen, Créteil, Dijon, La Tronche, Marseille, Paris, Suresnes
2022-11-22
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Strasbourg, Marseille, Dijon, Bordeaux, Nantes, Saint-Étienne-de-Montluc, Lyon, Rouen
2022-11-21
Active, closed
AstraZeneca
Observational
254
Angers, Argenteuil, Avignon, Bayonne, Bordeaux, Clermont-Ferrand, Créteil, Dijon
2022-11-14
Recruiting
Janssen Research & Development, LLC
Phase 2
520
Caen, Dijon, Nîmes, Paris, Saint-Herblain, Villejuif
2022-11-11
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Besançon, Avignon, Brest, Clermont-Ferrand, Créteil, Dijon, Lyon, Marseille
2022-10-24
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Créteil, Dijon, Lyon, Montpellier, Nantes, Nice, Paris, Pessac
2022-10-13
Rows per page Showing 1–500 of 815
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 October 2026. https://priyalifescience.com/clinical-trials-france/city/dijon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,698 studies in total at the last sync on 23 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 815 of those studies with a site in Dijon.

How many clinical trials are recruiting in Dijon?

453 of the 815 studies on this page are recruiting new participants as of the 23 Oct 2026, 03:20 UTC sync. A further 65 have not yet opened recruitment, 293 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Dijon), 815 studies
PhaseStudiesRecruitingShare
Phase 325311931%
Not applicable17111821%
Observational15210218.7%
Phase 21406317.2%
Phase 1/248275.9%
Phase 11852.2%
Phase 2/31792.1%
Phase 416102%

Most active sponsors

Lead sponsors with the most studies (Dijon)
Lead sponsorStudiesRecruiting
Centre Hospitalier Universitaire Dijon10287
AstraZeneca3611
UNICANCER3014
Centre Georges Francois Leclerc2510
Hospices Civils de Lyon2315
Assistance Publique - Hôpitaux de Paris2215
Merck Sharp & Dohme LLC209
Novartis Pharmaceuticals193
Bristol-Myers Squibb1610
Nantes University Hospital1511
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.